Showing results (6191-6200 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 30, 2007
The development of targeted therapies for hepatocellular cancerD Chattopadhyay, D M Manas, H L ReevesCurrent Pharmaceutical Design|November 30, 2007
Mass spectrometric imaging of the nervous systemS S Rubakhin, N G Hatcher, E B Monroe, et al.Current Pharmaceutical Design|November 30, 2007
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signalingRoberto Bianco, Vincenzo Damiano, Teresa Gelardi, et al.Current Pharmaceutical Design|November 30, 2007
Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapyJ Daniel Pennington, Kristi Muldoon Jacobs, Lunching Sun, et al.Current Pharmaceutical Design|November 30, 2007
Cancer control by phytochemicalsHoyoku Nishino, Yoshiko Satomi, Harukuni Tokuda, et al.Current Pharmaceutical Design|November 30, 2007
Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxicationsKamil Kuca, Daniel Jun, Jiri BajgarCurrent Pharmaceutical Design|February 14, 2006
Exploiting high-throughput ion channel screening technologies in integrated drug discoveryJ M TreherneCurrent Pharmaceutical Design|February 14, 2006
Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseasesY YatomiCurrent Pharmaceutical Design|February 14, 2006
gamma-secretase as a therapeutic target for treatment of Alzheimer's diseaseTaisuke Tomita, Takeshi IwatsuboCurrent Pharmaceutical Design|February 14, 2006
Antigonadotropins: a novel strategy to halt Alzheimer's disease progressionChristopher W Gregory, Craig S Atwood, Mark A Smith, et al.Pageof 1,008